Skip to Content

Neogen Corp NEOG

Morningstar Rating
$16.31 −0.57 (3.35%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

NEOG is trading at a 885% premium.
Price
$16.88
Fair Value
$21.49
Uncertainty
High
1-Star Price
$67.95
5-Star Price
$29.68
Economic Moat
Nvjd
Capital Allocation
Lgfmbdff
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NEOG is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$16.88
Day Range
$16.2516.83
52-Week Range
$11.4724.10
Bid/Ask
$16.31 / $16.32
Market Cap
$3.54 Bil
Volume/Avg
572,036 / 2.1 Mil

Key Statistics

Price/Earnings (Normalized)
35.11
Price/Sales
3.93
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety (70% of post-merger sales), Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety (20% of post-merger sales), Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for 60% of total revenue, while international markets, including Canada, Europe, Asia, and Latin America, account for the remaining 40%.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Core
Total Number of Employees
2,640

Comparables

Valuation

Metric
NEOG
300942
688317
Price/Earnings (Normalized)
35.1139.03
Price/Book Value
1.163.360.73
Price/Sales
3.9311.9811.31
Price/Cash Flow
29.88105.3025.68
Price/Earnings
NEOG
300942
688317

Financial Strength

Metric
NEOG
300942
688317
Quick Ratio
2.175.3114.78
Current Ratio
3.825.7316.22
Interest Coverage
0.91−9.69−519.01
Quick Ratio
NEOG
300942
688317

Profitability

Metric
NEOG
300942
688317
Return on Assets (Normalized)
2.31%−13.04%−3.23%
Return on Equity (Normalized)
3.35%−19.26%−3.43%
Return on Invested Capital (Normalized)
3.92%−14.12%−4.54%
Return on Assets
NEOG
300942
688317
See how this stock stacks up to its competitors with Morningstar Investor

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
ZfvrylvwjXhzm$206.4 Bil
Danaher Corp
DHR
YhsfxvnqmnQxfyw$181.3 Bil
IQVIA Holdings Inc
IQV
VnddjswyhYjnyxf$41.0 Bil
IDEXX Laboratories Inc
IDXX
BcjfvxplypXthdzy$38.9 Bil
Agilent Technologies Inc
A
SkmzdmfmqVjng$38.5 Bil
Mettler-Toledo International Inc
MTD
PvbpfgnprGqccxc$29.0 Bil
Icon PLC
ICLR
GsrtpcxGmprhm$27.1 Bil
Illumina Inc
ILMN
ZqvwlcrwRltbjw$18.4 Bil
Waters Corp
WAT
MsrztfdgbWyykn$18.3 Bil
Labcorp Holdings Inc
LH
WwswqfykwyXlwhl$18.1 Bil

Sponsor Center